 |
 |
| |
Mikael Ørum,
Partner |
 |
 |
| |
Peter
Damsbo, MD,
Partner |
 |
 |
| |
Robert L. Buchanan , PhD,
Attorney at Law, Partner |
|
Martin Austin,
Partner
|
 |
 |
| |
Dede Willis, BSc, MBA,
Partner |
 |
 |
| |
Christina Wagner, PhD, Partner |
 |
 |
| |
Mirko
Stange, PhD,
Partner |
 |
 |
| |
Madeline
Yap, PhD,
Partner |
 |
 |
| |
Konstantinos Alevizopoulos, PhD, Partner |
 |
 |
| |
Spencer Ma MBA, FCPA, ACIS ,
Partner |
 |
 |
| |
Bengt Westrin, PhD, Assoc. Professor,
Partner |
 |
 |
| |
Pieter
Telleman, PhD, MBA,
Senior Advisor |
 |
 |
| |
Lars Hedbys,
M Sc, PhD,
Senior Advisor |
 |
 |
|
 |
| |
| |
|
|
Our Team
Lars
Hedbys, M Sc, PhD |
Senior Advisor
Dr. Lars Hedbys joined Ventac Partners in August 2006. He has over 25 years of life science industry and science experience including over 15 years in senior and executive management positions in the life science industry.
Lars Hedbys contributes with an extensive experience in drug development, product strategy development and business development. He has a track record of leading large operational organizations, organizations in change as well as managing rapid growth
in young private companies. He is also co founder of Regenesance BV and Idogen AB. His experience also includes a number of board membership roles.
Important positions in his curriculum outside Ventac Partners include: CEO, AB Mando (Sweden), General Manager, Synarc A/S (Denmark), Vice President and Site General Manager, AstraZeneca R&D Lund (Sweden) and Vice President, Global Clinical Operations & Project Management, AstraZeneca R&D.
Dr Hedbys holds a M. Sc. in chemical engineering from Chalmers
University and a PhD in Applied Biochemistry from the University
of Lund. |
|

Lars Hedbys, PhD
Senior Advisor |
|
|